6 March 2017 · The posted documents are proceedings of the NHS Pharmaceutical Quality Assurance Committee. They are advice notes written to address issues which have arisen in previous…
8 September 2020 · NICE guidance providing good practice recommendations for individual people and organisations involved with the development, authorisation and use PGDs.
22 February 2022 · Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input
16 September 2022 · A summary of the implications of the UKs exit from the EU for clinical trial sites for both IMP and ATIMPs, including supply to and from Northern Ireland
24 May 2010 · This guidance document is based on an information developed by the London & SE QA Group and guidance documents produced by Quality Control North West. This…
16 November 2016 · The purpose of this document is to provide detailed guidance on the pharmaceutical quality assessment of unlicensed medicines. The principles are applicable both to unlicensed…